October 25, 2006
Bisphosphonates and Osteonecrosis of the Jaw
In support of yesterday's excellent and well attended presentation by Dr. Joseph Helman, we would like to offer the following selected resources on bisphosphonates and osteonecrosis of the jaw. Sections below include information for patients, for practitioners, and articles from the professional literature.
Please note that while links to articles and abstracts are provided as possible, to get access to the full article you may need to navigate to the article from a UM Library service. One way to do this would be to enter PubMed from a UM web page, log in if off campus, and then enter the PMID number. Go to the bottom of the resulting page, and click on the block-M.
For those who would like more information, custom searches in PubMed are provided.
* INFORMATION FOR PATIENTS
ADA: Oral Health Topics: Osteonecrosis of the Jaw: http://www.ada.org/public/topics/osteonecrosis.asp
AGD: Treatment drug may cause jaw bone to die: http://www.agd.org/media/2006/june/treatment.asp
NIAMS: Oral Health and Bone Disease: http://www.niams.nih.gov/bone/hi/oralhealth_bone.htm
* INFORMATION FOR PROFESSIONALS
ADA: A-Z Topics: Osteonecrosis of the Jaw: http://www.ada.org/prof/resources/topics/osteonecrosis.asp
ADA Council on Scientific Affairs. Expert Panel Recommendations: Dental Management of Patients on Oral Bisphosphonate Therapy. June 2006. [PDF, 159K]
Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. Abstract.
J Am Dent Assoc. 2005 Dec;136(12):1658-68. Review. Erratum in: J Am Dent Assoc. 2006 Jan;137(1):26.
NIDCR: Oral Care Provider's Reference Guide for Oncology Patients: http://www.nidcr.nih.gov/HealthInformation/DiseasesAndConditions/CancerTreatmentAndOralHealth/Oral%20Care%20Providers%20Reference%20Guide%20for%20Oncology%20Patients.htm
Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, Fenton R, Gahres N, Sausville E, Ord R, Meiller T.
Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. Abstract.
J Clin Oncol. 2006 Feb 20;24(6):945-52.
Lacy MQ, Dispenzieri A, Gertz MA, Greipp PR, Gollbach KL, Hayman SR, Kumar S, Lust JA, Rajkumar SV, Russell SJ, Witzig TE, Zeldenrust SR, Dingli D, Bergsagel PL, Fonseca R, Reeder CB, Stewart AK, Roy V, Dalton RJ, Carr AB, Kademani D, Keller EE, Viozzi CF, Kyle RA.
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.
Mayo Clin Proc. 2006 Aug;81(8):1047-53. Review.
Marx RE, Sawatari Y, Fortin M, Broumand V.
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Abstract.
J Oral Maxillofac Surg. 2005 Nov;63(11):1567-75.
Nase JB, Suzuki JB.
Osteonecrosis of the jaw and oral bisphosphonate treatment. Abstract.
J Am Dent Assoc. 2006 Aug;137(8):1115-9; quiz 1169-70.
Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL.
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.Abstract.
J Oral Maxillofac Surg. 2004 May;62(5):527-34.
Scully C, Madrid C, Bagan J.
Dental endosseous implants in patients on bisphosphonate therapy. Abstract.
Implant Dent. 2006 Sep;15(3):212-8.
* WANT MORE?
Pubmed Search: Bisphosphonates and Osteonecrosis of the Jaw
Pubmed Search (Free Full Text Only): Bisphosphonates and Osteonecrosis of the Jaw
Posted by pfa at October 25, 2006 01:12 PM